1-8 of 8
Suzanne Chanel
Close
Sort by
Journal Articles

Effects of Long Term Imatinib on Bone Mineral Density In Patients with Chronic Myelogenous Leukemia (CML) or Gastrointestinal Stromal Tumor (GIST)

Ellin Berman, MD, Robert Maki, MD, PhD, Azeez Farooki, MD, Monica Girotra, MD, Suzanne Chanel, RN, Catherine Cheng, BA, H. William Strauss, MD, Martin Fleisher, PhD
Journal: Blood
Blood (2010) 116 (21): 2276.
https://doi.org/10.1182/blood.V116.21.2276.2276
Published: 2010
Journal Articles

A Phase I Study of the Potent Hsp90 Inhibitor STA-9090 Administered Twice Weekly In Subjects with Hematologic Malignancies

Swaminathan Padmanabhan, MBBS, MD, Kevin R Kelly, MD, Mark Heaney, MD, PhD, Stephanie Hodges, Suzanne Chanel, RN, Mark Frattini, MD, Ronan Swords, MD, MRCPI, FRCPath, Robert Bradley, Florentina Teofilovici, MD, MS, Daniel J DeAngelo, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2898.
https://doi.org/10.1182/blood.V116.21.2898.2898
Published: 2010
Journal Articles

Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemia

Clinical Trials & Observations
Peter G. Maslak, Tao Dao, Lee M. Krug, Suzanne Chanel, Tatyana Korontsvit, Victoria Zakhaleva, Ronghua Zhang, Jedd D. Wolchok, Jianda Yuan, Javier Pinilla-Ibarz, Ellin Berman, Mark Weiss, Joseph Jurcic, Mark G. Frattini, David A. Scheinberg
Journal: Blood
Blood (2010) 116 (2): 171–179.
https://doi.org/10.1182/blood-2009-10-250993
Published: 2010
Journal Articles

Sequential Cytarabine and Alpha-Particle Immunotherapy with Bismuth-213 ( 213 Bi)-Labeled-HuM195 (Lintuzumab) for Acute Myeloid Leukemia (AML)

Todd Rosenblat, MD, MS, Michael R. McDevitt, PhD, Deborah A. Mulford, MD, Neeta Pandit-Taskar, MD, Mark A. Weiss, MD, Mark L. Heaney, MD, PhD, Suzanne Chanel, RN, Alfred Morgenstern, PhD, Steven M. Larson, MD, David A. Scheinberg, MD, PhD, Joseph G. Jurcic, MD
Journal: Blood
Blood (2008) 112 (11): 2983.
https://doi.org/10.1182/blood.V112.11.2983.2983
Published: 2008
Journal Articles

Pilot Study of a Wilms Tumor Protein (WT1) Heteroclitic Peptide Vaccine in Patients with Myeloid and Thoracic Neoplasms.

Peter G. Maslak, MD, Lee Krug, MD, Suzanne Chanel, RN, Tao Dao, PhD, Leonard James, MD, PhD, Leslie Tyson, RN, Sara Bekele, BA, David A. Scheinberg, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 903.
https://doi.org/10.1182/blood.V110.11.903.903
Published: 2007
Journal Articles

Phase I Trial of the Targeted Alpha-Particle Nano-Generator Actinium-225 ( 225 Ac)-HuM195 (Anti-CD33) in Acute Myeloid Leukemia (AML).

Todd L. Rosenblat, MD, Michael R. McDevitt, PhD, Neeta Pandit-Taskar, MD, Jorge A. Carrasquillo, MD, Suzanne Chanel, RN, Mark G. Frattini, MD, PhD, Steven M. Larson, MD, David A. Scheinberg, MD, PhD, Joseph G. Jurcic, MD
Journal: Blood
Blood (2007) 110 (11): 910.
https://doi.org/10.1182/blood.V110.11.910.910
Published: 2007
Journal Articles

Induction with Combined Modality Therapy Followed by Immunomodulated Post Remission Therapy for Newly Diagnosed Acute Myeloid Leukemia (AML).

Seema Gupta, MD, Mark A. Weiss, MD, Joseph G. Jurcic, MD, Suzanne Chanel, RN, Bri-Anne Wilson, BA, Emily Biederman, BA, Ellin Berman, MD, David A. Scheinberg, MD, PhD, Peter G. Maslak, MD
Journal: Blood
Blood (2005) 106 (11): 2802.
https://doi.org/10.1182/blood.V106.11.2802.2802
Published: 2005
Journal Articles

Altered Bone and Mineral Metabolism in Patients Treated with Imatinb.

Ellin Berman, MD, Maria Nicolaides, MD, Nicolas Sauter, MD, Suzanne Chanel, RN, Brianne Wilson, Martin Fleisher, PhD
Journal: Blood
Blood (2004) 104 (11): 4668.
https://doi.org/10.1182/blood.V104.11.4668.4668
Published: 2004